Free tool
FAERS Monitor: Oxygen, Usp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205849 or its brand name (Oxygen, Usp, Oxygen). Reports on generic versions are filed under their own applications.
Reports
50,938
Serious
33,924
67% of reports
Hospitalization
21,642
Death reported
7,319
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea10,172
- cough5,446
- headache5,135
- diarrhoea4,547
- fatigue4,297
- nausea4,124
- pneumonia4,005
- dizziness3,637
- oxygen saturation decreased3,203
- death2,668
- hypotension2,432
- asthenia2,419
- malaise2,412
- off label use2,312
- weight decreased2,192
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 350 |
| 2005 | 354 |
| 2006 | 447 |
| 2007 | 487 |
| 2008 | 603 |
| 2009 | 735 |
| 2010 | 984 |
| 2011 | 1,098 |
| 2012 | 1,239 |
| 2013 | 1,421 |
| 2014 | 1,796 |
| 2015 | 2,038 |
| 2016 | 2,549 |
| 2017 | 2,254 |
| 2018 | 2,530 |
| 2019 | 2,119 |
| 2020 | 2,683 |
| 2021 | 2,018 |
| 2022 | 1,877 |
| 2023 | 3,532 |
| 2024 | 6,667 |
| 2025 | 7,567 |
| 2026 | 5,588 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,221 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| oxygen saturation decreasedSignal | 3,203 | 24.9 | 24.0 | 69,437 |
| coughSignal | 5,446 | 8.2 | 8.0 | 33,984 |
| dyspnoeaSignal | 10,172 | 7.5 | 7.4 | 58,195 |
| pneumoniaSignal | 4,005 | 5.2 | 5.0 | 13,466 |
| hypotensionSignal | 2,432 | 5.1 | 4.9 | 7,887 |
| headacheSignal | 5,135 | 3.4 | 3.3 | 8,898 |
| weight decreasedSignal | 2,192 | 3.3 | 3.1 | 3,451 |
| dizzinessSignal | 3,637 | 3.0 | 2.9 | 5,013 |
| diarrhoeaSignal | 4,547 | 2.9 | 2.8 | 5,887 |
| astheniaSignal | 2,419 | 2.7 | 2.6 | 2,548 |
| fatigueSignal | 4,297 | 2.3 | 2.2 | 3,209 |
| malaiseSignal | 2,412 | 2.3 | 2.2 | 1,755 |
| nauseaSignal | 4,124 | 2.2 | 2.1 | 2,646 |
| death | 2,668 | 1.3 | 1.2 | 169 |
| off label use | 2,312 | 1.1 | 1.0 | 18 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.